These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 23974181)

  • 1. ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient.
    Moon RB
    Int J Pharm Compd; 2006; 10(2):95-8. PubMed ID: 23974181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of the compound ABHR in hospice patients.
    Weschules DJ
    J Palliat Med; 2005 Dec; 8(6):1135-43. PubMed ID: 16351526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial Selection of Antiemetics in End-of-Life Care: A Retrospecitve Analysis.
    Tolen L; McMath JA; Alt C; Weschules DJ; Knowlton CH; McPherson ML
    Int J Pharm Compd; 2006; 10(2):147-53. PubMed ID: 23974188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physiological perspective for utility or futility of alcohol-based hand rub gel against nausea-vomiting: is it P-6 acupoint or transnasal aroma?
    Gupta D; Mazumdar A; Stellini M
    Am J Hosp Palliat Care; 2014 Sep; 31(6):608-10. PubMed ID: 23921290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials.
    Bleicher J; Bhaskara A; Huyck T; Constantino S; Bardia A; Loprinzi CL; Silberstein PT
    J Support Oncol; 2008 Jan; 6(1):27-32. PubMed ID: 18257398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABH gel is not absorbed from the skin of normal volunteers.
    Smith TJ; Ritter JK; Poklis JL; Fletcher D; Coyne PJ; Dodson P; Parker G
    J Pain Symptom Manage; 2012 May; 43(5):961-6. PubMed ID: 22560361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
    Kris MG; Gralla RJ; Clark RA; Tyson LB; Fiore JJ; Kelsen DP; Groshen S
    Cancer Treat Rep; 1985 Nov; 69(11):1257-62. PubMed ID: 3912039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABH Gel: Comforting Cure or Pricey Placebo?
    Blaszczyk AT; Bailey TA; Tapia S
    J Am Med Dir Assoc; 2021 Jan; 22(1):23-27. PubMed ID: 33246839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compounded drugs of value in outpatient hospice and palliative care practice.
    McNulty JP; Muller G
    Int J Pharm Compd; 2014; 18(3):190-200. PubMed ID: 25306765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a scheduled IV cocktail of antiemetics for the palliation of nausea and vomiting in a hospice population.
    Kumar G; Hayes KA; Clark R
    Am J Hosp Palliat Care; 2008; 25(3):184-9. PubMed ID: 18573994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nausea and vomiting.
    Hanna L
    BETA; 1997 Jun; ():23-6, 58. PubMed ID: 11364536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of controlled release metoclopramide and domperidone in the treatment of nausea and vomiting.
    Roy P; Patel NH; Miller AJ
    Br J Clin Pract; 1991; 45(4):247-51. PubMed ID: 1810356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol.
    Gupta M; Davis M; LeGrand S; Walsh D; Lagman R
    J Support Oncol; 2013 Mar; 11(1):8-13. PubMed ID: 23137588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nausea and vomiting].
    Fujii M
    Nihon Rinsho; 2003 Jun; 61(6):954-8. PubMed ID: 12806942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nausea and vomiting and cancer patients' quality of life: a discussion of Professor Selby's paper.
    Lindley CM; Hirsch JD
    Br J Cancer Suppl; 1992 Dec; 19():S26-9. PubMed ID: 1467197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounding nausea aid.
    Francom M
    Am Pharm; 1991 Jul; NS31(7):7. PubMed ID: 1951035
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of nausea, vomiting, and diarrhea during critical illness.
    Makic MB
    AACN Adv Crit Care; 2011; 22(3):265-74. PubMed ID: 21808162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
    Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ
    Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting adverse effects after short-term low-dose treatment with metoclopramide for vomiting.
    Dahl E; Diskin AL
    Int Marit Health; 2014; 65(1):16-9. PubMed ID: 24677122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis versus treatment: is there a better way to manage radiotherapy-induced nausea and vomiting?
    Horiot JC
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1018-25. PubMed ID: 15519770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.